Strength: 10/12.5 mg

7 tablets/blister, 2 blisters/box

Indications:

Hypertension.

This fixed-dose combination is not indicated for the initial treatment of hypertension (see "Dosage and Administration" for details).

This product is indicated for patients whose blood pressure is not adequately controlled by monotherapy. It may also be used as a substitute for the concomitant use of the individual components at the corresponding doses.

Strength: 10/12.5 mg

7 tablets/blister, 4 blisters/box

Indications:

Hypertension.

This fixed-dose combination is not indicated for the initial treatment of hypertension (see "Dosage and Administration" for details).

This product is indicated for patients whose blood pressure is not adequately controlled by monotherapy. It may also be used as a substitute for the concomitant use of the individual components at the corresponding doses.

　　Strength: 250 mg

　　10 tablets/blister, 1 blister/box

　　Indications:

　　1. Cholesterol gallstones—must be radiolucent, with normal gallbladder contractility;

　　2. Cholestatic liver disease (e.g., primary biliary cirrhosis);

　　3. Bile reflux gastritis

Specification: 45mg

30 capsules per bottle, 1 bottle per box

Indications:

On the basis of adult diet control:

1.For reducing triglyceride (TG) levels in patients with severe hypertriglyceridemia.

2. For the treatment of patients with primary hypercholesterolemia or mixed dyslipidemia.

Specification: 135mg

30 capsules per bottle, 1 bottle per box

Indications:

On the basis of adult diet control:

1.For reducing triglyceride (TG) levels in patients with severe hypertriglyceridemia.

2. For the treatment of patients with primary hypercholesterolemia or mixed dyslipidemia.

Specification: 0.36g

60 ml/ bottle, 1 bottle/box

Indications:

1. Treatment of influenza A and B in patients aged 2 weeks and older (oseltamivir phosphate is effective in treating influenza A and B, although clinical data regarding influenza B are limited). Treatment should be initiated within 48 hours of the onset of symptoms.

2. Prevention of influenza A and B in individuals aged 1 year and older.

Specification: 75mg, 150mg

12 capsules/plate, 2 plates/box

Indications:

Post herpetic neuralgia, fibromyalgia

Specification: 75mg, 150mg

12 capsules/plate, 2 plates/box

Indications:

Post herpetic neuralgia, fibromyalgia

Specification: 47.5mg

14 capsules/plate, 2 plates/box

Indications:

Isolated blood pressure. Angina. Symptomatically stable chronic heart failure with abnormal left ventricular systolic function.

Specification: 30mg, 120mg

5 tablets/plate, 2 plates/box

Indications:

Treatment of symptoms and signs of acute and chronic osteoarthritis, acute gouty arthritis, primary dysmenorrhea

Specification: 60mg

5 tablets/plate, 2 plates/box

Indications:

Treatment of symptoms and signs of acute and chronic osteoarthritis, acute gouty arthritis, primary dysmenorrhea.

Specification: 30mg

7 tablets/plate, 2plates/box

Indications:

Treatment of symptoms and signs of acute and chronic osteoarthritis, acute gouty arthritis, primary dysmenorrhea.

Strength: 20 mg

14 tablets/blister, 2 blisters/box

Indications:

This product is indicated for the treatment of depression, obsessive-compulsive disorder (OCD), panic disorder (with or without agoraphobia), and social phobia/social anxiety disorder. Following a satisfactory therapeutic response, continued use of this product can prevent the recurrence of depression, panic disorder, and OCD.

Strength: 20 mg

14 tablets/blister, 3 blisters/box

Indications:

This product is indicated for the treatment of depression, obsessive-compulsive disorder (OCD), panic disorder (with or without agoraphobia), and social phobia/social anxiety disorder. Following a satisfactory therapeutic response, continued use of this product can prevent the recurrence of depression, panic disorder, and OCD.

Specification:  0.2g

30 tablets

Indications:

Treatment of schizophrenia